Direct measurement of propranolol bioavailability during accumulation to steady-state.
Open Access
- 1 October 1978
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 6 (4), 345-350
- https://doi.org/10.1111/j.1365-2125.1978.tb00862.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Contribution of the liver to overall elimination of propranololJournal of Pharmacokinetics and Biopharmaceutics, 1976
- A physiological approach to hepatic drug clearanceCancer Cell, 1975
- GLC Determination of Propranolol, Other β-Blocking Drugs, and Metabolites in Biological Fluids and TissuesJournal of Pharmaceutical Sciences, 1974
- RATE OF ELIMINATION OF TRACER DOSES OF PHENYTOIN AT DIFFERENT STEADY-STATE SERUM PHENYTOIN CONCENTRATIONS IN EPILEPTIC PATIENTSBritish Journal of Clinical Pharmacology, 1974
- A sensitive gas chromatographic method for the determination of propranolol in human plasmaJournal of Chromatography A, 1973
- Disposition of propranolol V. Drug accumulation and steady‐state concentrations during chronic oral administration in manClinical Pharmacology & Therapeutics, 1973
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- The pharmacodynamics and metabolism of propranolol in manEuropean Journal of Clinical Pharmacology, 1970
- Plasma propranolol levels in adults With observations in four childrenCancer Cell, 1970